Merck & Co. Inc. buy Scotiabank
Start price
14.11.25
/
50%
€78.80
Target price
14.11.26
-
Performance (%)
26.40%
Price
18.03.26
€99.60
Summary
This prediction is currently active. The prediction currently has a performance of 26.40%. This prediction currently runs until 14.11.26. The prediction end date can be changed by Scotiabank at any time. Scotiabank has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Merck & Co. Inc. | -0.797% | -0.797% |
| iShares Core DAX® | -2,12 % | -8,18 % |
| iShares Nasdaq 100 | -1,13 % | 0,91 % |
| iShares Nikkei 225® | -0,66 % | -6,26 % |
| iShares S&P 500 | -1,26 % | -1,00 % |
Comments by Scotiabank for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (NYSE:MRK) was upgraded by analysts at Scotiabank to a "strong-buy" rating.
Ratings data for MRK provided by MarketBeat